Non-injectable Insulin
REPORT SCOPE:
The report provides a comprehensive summary of the Non-injectable insulin market, along with detailed profiles of key market players that include revenue product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. The report discusses strategies adopted by emerging market players, with recommendations for new market entrants. This research study discusses historical, current and potential market size. The report will help market players and new entrants make informed decisions about the production and export of goods and services. Organizations, distributors and exporters should find the information about market development and trends useful. The study segments the market according to applications and end uses. Geographical market analysis is provided for all major segments.
REPORT INCLUDES:
The report provides a comprehensive summary of the Non-injectable insulin market, along with detailed profiles of key market players that include revenue product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. The report discusses strategies adopted by emerging market players, with recommendations for new market entrants. This research study discusses historical, current and potential market size. The report will help market players and new entrants make informed decisions about the production and export of goods and services. Organizations, distributors and exporters should find the information about market development and trends useful. The study segments the market according to applications and end uses. Geographical market analysis is provided for all major segments.
REPORT INCLUDES:
- An overview of the global market for non-injectable insulin
- Analyses of market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Information on recent major technical advances in different forms of non-injectable insulin
- A look at the key areas of growth and adoption rate of non-injectable insulin among both commercial customers and regulatory authorities
- Examination of strategies of the major players in the market and the impact of new technological developments
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Future Market Potential and Investment Analysis
North America Will be the Largest and Fastest-Growing Market
CHAPTER 4 MARKET BREAKDOWN BY FORM
Pills
Spray
Others (Film and Chewing Gum)
CHAPTER 5 MARKET BREAKDOWN BY SOURCE
Synthetic Insulin
Semisynthetic Insulin
CHAPTER 6 MARKET BREAKDOWN BY REGION
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
CHAPTER 7 COMPETITIVE LANDSCAPE
CHAPTER 8 COMPANY PROFILES
ACCESS PHARMACEUTICALS INC. (ABEONA THERAPEUTICS INC.)
AERAMI THERAPEUTICS
BIOCON LTD.
BIODEL INC. (ALBIREO LTD.)
BIONOVA LIFESCIENCES
BOSTON THERAPEUTICS INC.
COROMED INC.
DIABETOLOGY LTD.
DIASOME PHARMACEUTICALS INC.
EMISPHERE TECHNOLOGIES INC.
GENEREX BIOTECHNOLOGY CORP.
MIDATECH PHARMA PLC
ORAMED PHARMACEUTICALS INC.
RANI THERAPEUTICS
SHREYA LIFE SCIENCES PVT. LTD.
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Future Market Potential and Investment Analysis
North America Will be the Largest and Fastest-Growing Market
CHAPTER 4 MARKET BREAKDOWN BY FORM
Pills
Spray
Others (Film and Chewing Gum)
CHAPTER 5 MARKET BREAKDOWN BY SOURCE
Synthetic Insulin
Semisynthetic Insulin
CHAPTER 6 MARKET BREAKDOWN BY REGION
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
CHAPTER 7 COMPETITIVE LANDSCAPE
CHAPTER 8 COMPANY PROFILES
ACCESS PHARMACEUTICALS INC. (ABEONA THERAPEUTICS INC.)
AERAMI THERAPEUTICS
BIOCON LTD.
BIODEL INC. (ALBIREO LTD.)
BIONOVA LIFESCIENCES
BOSTON THERAPEUTICS INC.
COROMED INC.
DIABETOLOGY LTD.
DIASOME PHARMACEUTICALS INC.
EMISPHERE TECHNOLOGIES INC.
GENEREX BIOTECHNOLOGY CORP.
MIDATECH PHARMA PLC
ORAMED PHARMACEUTICALS INC.
RANI THERAPEUTICS
SHREYA LIFE SCIENCES PVT. LTD.
LIST OF TABLES
Summary Table: Global Market for Non-injectable Insulin, by Region, Through 2024
Table 1: Other Products Related to Non-injectable Insulin
Table 2: Examples of Non-injectable Insulin Products
Table 3: Global Market for Non-injectable Insulin, by Form, Through 2024
Table 4: Global Market for Edible Insulin Pills, by Region, Through 2024
Table 5: Global Market for Insulin Sprays, by Region, Through 2024
Table 6: Global Market for Other Forms of Non-injectable Insulin, by Region, Through 2024
Table 7: Global Market for Non-injectable Insulin, by Source, Through 2024
Table 8: Global Market for Synthetic Non-injectable Insulin, by Region, Through 2024
Table 9: Global Market for Semisynthetic Non-injectable Insulin, by Region, Through 2024
Table 10: Global Market for Non-injectable Insulin, by Region, Through 2024
Table 11: Top 10 Countries with the Highest Prevalence of Diabetes Across the Globe, 2019
Table 12: North American Market for Non-injectable Insulin, by Form, Through 2024
Table 13: North American Market for Non-injectable Insulin, by Source, Through 2024
Table 14: Prevalence of Diabetes in North American Countries, 2010-2017
Table 15: Prevalence of Diabetes in North America, 2019-2045
Table 16: Prevalence of Diabetes in Europe, 2019-2045
Table 17: European Market for Non-injectable Insulin, by Form, Through 2024
Table 18: European Market for Non-injectable Insulin, by Source, Through 2024
Table 19: Existing National Diabetes Plans in Europe, by Country
Table 20: Prevalence of Diabetes in Asia-Pacific, 2019-2045
Table 21: Asia-Pacific Market for Non-injectable Insulin, by Form, Through 2024
Table 22: Asia-Pacific Market for Non-injectable Insulin, by Source, Through 2024
Table 23: Rest of the World Market for Non-injectable Insulin, by Form, Through 2024
Table 24: Rest of the World Market for Non-injectable Insulin, by Source, Through 2024
Summary Table: Global Market for Non-injectable Insulin, by Region, Through 2024
Table 1: Other Products Related to Non-injectable Insulin
Table 2: Examples of Non-injectable Insulin Products
Table 3: Global Market for Non-injectable Insulin, by Form, Through 2024
Table 4: Global Market for Edible Insulin Pills, by Region, Through 2024
Table 5: Global Market for Insulin Sprays, by Region, Through 2024
Table 6: Global Market for Other Forms of Non-injectable Insulin, by Region, Through 2024
Table 7: Global Market for Non-injectable Insulin, by Source, Through 2024
Table 8: Global Market for Synthetic Non-injectable Insulin, by Region, Through 2024
Table 9: Global Market for Semisynthetic Non-injectable Insulin, by Region, Through 2024
Table 10: Global Market for Non-injectable Insulin, by Region, Through 2024
Table 11: Top 10 Countries with the Highest Prevalence of Diabetes Across the Globe, 2019
Table 12: North American Market for Non-injectable Insulin, by Form, Through 2024
Table 13: North American Market for Non-injectable Insulin, by Source, Through 2024
Table 14: Prevalence of Diabetes in North American Countries, 2010-2017
Table 15: Prevalence of Diabetes in North America, 2019-2045
Table 16: Prevalence of Diabetes in Europe, 2019-2045
Table 17: European Market for Non-injectable Insulin, by Form, Through 2024
Table 18: European Market for Non-injectable Insulin, by Source, Through 2024
Table 19: Existing National Diabetes Plans in Europe, by Country
Table 20: Prevalence of Diabetes in Asia-Pacific, 2019-2045
Table 21: Asia-Pacific Market for Non-injectable Insulin, by Form, Through 2024
Table 22: Asia-Pacific Market for Non-injectable Insulin, by Source, Through 2024
Table 23: Rest of the World Market for Non-injectable Insulin, by Form, Through 2024
Table 24: Rest of the World Market for Non-injectable Insulin, by Source, Through 2024
LIST OF FIGURES
Summary Figure: Global Market for Non-injectable Insulin, by Region, 2018-2024
Figure 1: Global Prevalence of Diabetes in the 20-79 Year Age Group, 2011-2045*
Figure 2: Global Diabetes Prevalence, 2019-2045
Figure 3: Novo Nordisk Revenue Share, by Region, 2018
Figure 4: Eli Lilly Revenue Share, by Segment, 2018
Figure 5: Nektar Therapeutics Revenue Share, by Region, 2018
Summary Figure: Global Market for Non-injectable Insulin, by Region, 2018-2024
Figure 1: Global Prevalence of Diabetes in the 20-79 Year Age Group, 2011-2045*
Figure 2: Global Diabetes Prevalence, 2019-2045
Figure 3: Novo Nordisk Revenue Share, by Region, 2018
Figure 4: Eli Lilly Revenue Share, by Segment, 2018
Figure 5: Nektar Therapeutics Revenue Share, by Region, 2018
